Skip to main content
Pharmanutra logo

Pharmanutra — Investor Relations & Filings

Ticker · PHN ISIN · IT0005274094 LEI · 815600F8217BC7733697 XMIL Manufacturing
Open in API
Filings indexed 601 across all filing types
Latest filing 2021-03-31 Governance Information
Country IT Italy
Listing XMIL PHN

About Pharmanutra

http://www.pharmanutra.it

PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.

Recent filings

Filing Released Lang Actions
PHARMANUTRA SPA RELAZIONE SUL GOVERNO SOCIETARIO E GLI ASSETTI PROPRIETARI 2020
Governance Information Classification · 1% confidence The document title is "RELAZIONE SUL GOVERNO SOCIETARIO E GLI ASSETTI PROPRIETARI DI PHARMANUTRA S.P.A." (Report on Corporate Governance and Ownership Structure of Pharmanutra S.p.A.). It explicitly states it is prepared pursuant to art. 123-bis of the Italian Legislative Decree 58/1998 (TUF). The table of contents details sections covering capital structure, board composition, committees, remuneration, internal controls, and shareholder meetings, all standard components of a Corporate Governance Report in the Italian regulatory context. This directly corresponds to the definition of Governance Information (CGR), which covers internal rules, board structure, and governance practices.
2021-03-31 Italian
PHARMANUTRA SPA FINANCIAL STATEMENTS 2020
Annual Report Classification · 1% confidence The document is titled 'ANNUAL FINANCIAL REPORT' for the period ending 31st December 2020. It contains comprehensive financial statements, including the Consolidated Balance Sheet, Income Statement, Cash Flow Statement, and explanatory notes for both the Group and the Parent Company (PharmaNutra S.p.A.). It also includes a Management Report and an Auditor's Report. This aligns perfectly with the definition of an Annual Report (10-K). FY 2020
2021-03-31 English
PHARMANUTRA SPA - RELAZIONE FINANZIARIA ANNUALE 2020
Annual Report Classification · 1% confidence The document is titled 'RELAZIONE FINANZIARIA ANNUALE' (Annual Financial Report) for the fiscal year ending December 31, 2020. It contains comprehensive financial statements, including the Consolidated Financial Statements and the Statutory Financial Statements of PharmaNutra S.p.A., along with management reports, notes, and audit information. This aligns with the definition of a 10-K (Annual Report). FY 2020
2021-03-31 Italian
PR - PHN shareholders meeting documents
Report Publication Announcement Classification · 1% confidence The document is a regulatory announcement (Informazione Regolamentata) from Pharmanutra S.p.A. The subject line is 'PR - PHN shareholders meeting documents'. The text explicitly states that documents for the Shareholders' Meeting (which typically relates to the AGM) are now available at the registered office and on the company website. The document itself is very short (4007 characters) and its primary function is to announce the availability of other materials, rather than being the material itself (like the full AGM presentation or the financial statements). This fits the definition of a Report Publication Announcement (RPA), as it announces the publication/availability of required documents for an upcoming meeting. It is not the DEF 14A (Proxy Statement) or the AGM-R (Presentation), but the announcement of their filing/availability.
2021-03-25 English
CS - PHN documentazione assemblea degli azionisti
AGM Information Classification · 1% confidence The document is a regulatory announcement (Informazione Regolamentata) from Pharmanutra S.p.A. The subject (Oggetto) is 'CS - PHN documentazione assemblea degli azionisti' (Shareholders' meeting documentation). The text explicitly states that the Administrators' Reports for the meeting agenda items are available, along with details about the upcoming shareholders' meeting (Assemblea degli azionisti) scheduled for April 26, 2021, concerning the approval of the 2020 Financial Statements. This content directly relates to the preparation and materials for the Annual General Meeting (AGM). Since the document itself is an announcement stating where the AGM documentation is located ('Vedi allegato' and listing locations), and it concerns the meeting itself, the most appropriate classification is AGM Information (AGM-R). It is not the full proxy statement (PSI) or the full annual report (10-K), but the notice regarding the AGM materials.
2021-03-25 Italian
Pharmanutra S.p.A. - Explanatory Memorandum on Authorisation to purchase and use trasury shares
AGM Information Classification · 1% confidence The document is titled "BOARD OF DIRECTORS' MEMORANDUM ON THE ITEMS ON THE AGENDA OF THE ORDINARY SHAREHOLDERS' MEETING" and specifically details a proposal regarding the "purchase and disposal of ordinary treasury shares." This action (share repurchase/dealing in own shares) is a specific corporate finance activity. The resolution section explicitly authorizes the purchase and disposal of own shares. This directly maps to the definition for Transaction in Own Shares (POS). Although it relates to a shareholders' meeting agenda, the core subject matter is the share transaction authorization, not the general meeting materials (AGM-R) or the voting results (DVA).
2021-03-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.